Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 22, 2018

Study Completion Date

June 22, 2018

Conditions
Apneic Oxygenation
Interventions
DRUG

0 L/min oxygen via conventional nasal cannulae

Patients will have conventional nasal cannulae placed under chin prior to induction of anesthesia. Immediately post-induction these will be placed into the nares. They will be removed from the nares at the end of the study when the airway has been secured. There will be no oxygen flowing through the cannulae in this group during the study.

DRUG

15 L/min oxygen via conventional nasal cannulae

Patients will have conventional nasal cannulae placed under chin prior to induction of anesthesia. Immediately post-induction these will be placed into the nares. They will be removed from the nares at the end of the study when the airway has been secured. There will be 15 L/min of oxygen flowing through the cannulae in this group during the study.

DRUG

60 L/min oxygen via high-flow nasal cannulae

Patients will have high-flow nasal cannulae placed under chin prior to induction of anesthesia. Immediately post-induction these will be placed into the nares. They will be removed from the nares at the end of the study when the airway has been secured. There will be 60 L/min of oxygen flowing through the cannulae in this group during the study.

Trial Locations (1)

Unknown

Halifax Infirmary, QEII Health Sciences Centre, Halifax

All Listed Sponsors
collaborator

Dalhousie University

OTHER

lead

Nova Scotia Health Authority

OTHER

NCT02755389 - Apneic Oxygenation Via Nasal Cannulae: 15 L/Min vs High-Flow | Biotech Hunter | Biotech Hunter